KEYTRUDA®Now Registered To Treat Malignant Pleural Mesothelioma, Biliary Tract C...
Friday, 28 March 2025, 9:04 am Press Release: MSD Auckland, New Zealand, March 28th, 2025 MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK) announced today that KEYTRUDA is now registered to treat patients with the following cancers: …